Haemonetics · 18 hours ago
Intern - Manufacturing Engineer
Haemonetics is a company that provides blood management solutions for the blood supply chain. The Manufacturing Engineer Intern will support the Manufacturing Engineering team with process improvement activities and optimize manufacturing processes and material flow within the facility.
BiotechnologyConsultingHealth CareMedicalMedical Device
Responsibilities
Support the Manufacturing Engineering team with process improvement activities; updating and documenting procedures and performing verification steps
Support the verification of the Overall Equipment Effectiveness (OEE) software platform
Collect data on manufacturing processes to support developing a process baseline and also the verification of data collection processes
Comply with all ISO 14001 and 13485 requirements
Comply with internal environmental management system requirements, as applicable
Qualification
Required
Current standing as a Rising Sophomore, Junior, Senior or Graduate student actively enrolled in an accredited Engineering or related field Undergraduate or Graduate program, required
Prior internship experience, leadership experience, or relevant coursework
Experience with Microsoft Office, including Word, Excel, and PowerPoint
Strong technical writing, analytical and communication skills
Detail-oriented with an emphasis on quality work products
Highly motivated, self-starter with demonstrated experience working with teams
Company
Haemonetics
Haemonetics is a provider of blood and plasma supplies and services.
H1B Sponsorship
Haemonetics has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (2)
2024 (3)
2023 (3)
2022 (2)
2021 (4)
Funding
Current Stage
Public CompanyTotal Funding
$1.75B2024-05-21Post Ipo Debt· $600M
2021-03-01Post Ipo Equity· $435M
2019-05-23Post Ipo Equity· $10M
Leadership Team
Recent News
2026-01-03
2025-12-02
2025-11-21
Company data provided by crunchbase